Alvesco for the Therapy of Persistent Asthma With or Without Allergic Component.
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2016
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms ATEM
- Sponsors Takeda Pharmaceuticals International GmbH
- 04 May 2012 Company added as trial association as reported by ClinicalTrials.gov.
- 04 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 May 2011 Planned end date changed from 1 Mar 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.